Eli Lilly’s obesity pill gets FDA approval, setting up tough competition with Novo Nordiskstatnews.com
FDA approves new Eli Lilly weight loss pill, Foundaiothe new York Times
Weight loss drug rivalry heats up as another GLP-1 pill gets FDA approvalscientific American
Wall Street hails multibillion-dollar bid for Lilly’s obesity pill despite Novo’s gainsreuters
The FDA has approved Lilly’s Foundaio™ (orfoglypron), the only GLP-1 pill for weight loss that can be taken at any time of the day without food or water restrictions.Eli Lilly
